eTheRNA
PrivateLast Round
Series B
Extension
Aug 23, 2022
Total Funding Raised
$103.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
eTheRNA is a biotechnology company that provides mRNA and lipid nanoparticle (LNP) technology platforms for the development and manufacturing of RNA-based therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
eTheRNA Comparables
Compare eTheRNA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acuitas Therapeutics | 86% | |
| Genevant Sciences | 84% | |
| Pantherna Therapeutics | 83% | |
eTheRNA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Aug 23, 2022 | ||||
| Series B | Jun 16, 2020 | ||||
| Series A | Mar 17, 2016 |
Key People
Founding team and executive leadership
eTheRNA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yijing Capital | Series B |
| Omega Funds | Series B Extension, Series A, Series B |
| EQT Life Sciences | Series B Extension, Series B, Series A |
| Fund+ | Series B Extension, Series A, Series B |
| Novalis LifeSciences | Series B Extension, Series B |
| PMV | Series B Extension, Series B, Series A |
| Yijing Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2026
Monthly visitors grew 48% MoM, reaching 7.8K.
- Mar 17, 2016
$27M round led by EQT Life Sciences and PMV.
eTheRNA Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about eTheRNA's valuation, stock price, and market status.